Moussa B. H. Youdim (, ; born, February 28, 1940) is an Israeli neuroscientist specializing in neurochemistry and neuropharmacology. He is the discoverer of both monoamine oxidase (MAO) B inhibitors l-deprenyl (

Selegiline Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl, Zelapar, and Emsam among others, is a medication which is used in the treatment of Parkinson's disease and major depressive disorder. It has also been studied and us ...

) and rasagiline ( Azilect) as anti-Parkinson drugs which possess neuroprotective activities. He is currently professor emeritus at Technion - Faculty of Medicine and President of Youdim Pharmaceuticals.

Industry involvement

Youdim served as consultant to

Roche F. Hoffmann-La Roche AG, commonly known as Roche (), is a Switzerland, Swiss multinational corporation, multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, ...

TEVA Pharmaceuticals Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational Pharmaceutical industry, pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drug ...

Ltd; Ciba Geigy, and Continental Pharmaceuticals, Brussels. He is president and CSO of Youdim Pharmaceutical. He is a discoverer of the anti-Parkinson drugs selelgiline (l-deprenyl) and developer of monoamine oxidase B inhibitor rasagiline (Azilect), which was considered to be the first disease modifying drug used for Parkinson's disease and TVP 3326, ladostigil, for Alzheimer's disease. Experts have recently questioned whether rasagiline actually has significant disease modifying properties.

Editorial boards

On the editorial boards of 40 journals, including '' British Journal of Pharmacology'', '' Journal of Neurochemistry'', '' Journal of Neural Transmission'', '' Experimental Neurology'', ''International Neurochemistry'', ''Psychopharmacology''. '' International Journal of Neuropsychopharmacology'', ''Archives of Pharmacology'', '' Frontiers in Pharmacology'', '' European Journal of Pharmacology'', ''Biogenic Amines'', '' Neuropsychobiology'', '' Neurochemical Research''; ''

Brain Research ''Brain Research'' is a peer-reviewed scientific journal focusing on several aspects of neuroscience. It publishes research reports and " minireviews". The editor-in-chief is Matthew J. LaVoie (University of Florida). Until 2011, full reviews were ...

'', '' CNS Drug Review'', ''Future Drugs'', ''Drugs of Today'', and '' Neurotherapeutics''.

Publications

* * * *

References

External links

* * * * Technion
Prof. Emeritus Moussa Youdim is the recipient of the Israel Prize in Life Sciences for 2022
Retrieved 2022-04-10. * American Technion Society
Prof. Emeritus Moussa Youdim Wins Prestigious Israel Prize in Life Sciences
Retrieved 2022-04-10. {{DEFAULTSORT:Youdim, Moussa B. H. 1940 births Israeli expatriates in the United Kingdom Israeli expatriates in the United States Israeli expatriates in Canada Iranian emigrants to Israel Scientists from Tehran Living people Israeli Mizrahi Jews Israeli neuroscientists Academic staff of Technion – Israel Institute of Technology Israel Prize recipients